Sign in

CIK 0000818033 · Accelerated filer

HERON THERAPEUTICS, INC. /DE/

Sign in to watch
Ticker
HRTX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
942875566
Phone
8582514400
Business address
4242 CAMPUS POINT COURT, SUITE 200, SAN DIEGO, CA, 92121
Former names
AP PHARMA INC /DE/, ADVANCED POLYMER SYSTEMS INC /DE/
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2022-01-13 Quart Barry D Chief Executive Officer Shares withheld for taxes −5,219 $8.30 $43K 116,635
2022-01-13 Quart Barry D Chief Executive Officer Option exercise · Restricted Stock Units −3,646 40,104
2022-01-13 Quart Barry D Chief Executive Officer Option exercise · Restricted Stock Units −16,122 179,295
2022-01-13 POYHONEN JOHN President & CCO Option exercise +1,250 25,086
2022-01-13 POYHONEN JOHN President & CCO Option exercise +4,564 29,650
2022-01-13 POYHONEN JOHN President & CCO Shares withheld for taxes −2,012 $8.30 $17K 27,638
2022-01-13 POYHONEN JOHN President & CCO Option exercise · Restricted Stock Units −1,250 13,750
2022-01-13 POYHONEN JOHN President & CCO Option exercise · Restricted Stock Units −4,564 50,756
2022-01-13 Peraza Lisa VP, Chief Accounting Officer Option exercise +552 14,749
2022-01-13 Peraza Lisa VP, Chief Accounting Officer Option exercise +1,933 16,682
2022-01-13 Peraza Lisa VP, Chief Accounting Officer Shares withheld for taxes −966 $8.30 $8K 15,716
2022-01-13 Peraza Lisa VP, Chief Accounting Officer Option exercise · Restricted Stock Units −552 6,073
2022-01-13 Peraza Lisa VP, Chief Accounting Officer Option exercise · Restricted Stock Units −1,933 21,491
2022-01-13 MANHARD KIMBERLY EVP, Drug Development Option exercise +1,250 4,518
2022-01-13 MANHARD KIMBERLY EVP, Drug Development Option exercise +4,564 9,082
2022-01-13 MANHARD KIMBERLY EVP, Drug Development Shares withheld for taxes −2,012 $8.30 $17K 7,070
2022-01-13 MANHARD KIMBERLY EVP, Drug Development Option exercise · Restricted Stock Units −1,250 13,750
2022-01-13 MANHARD KIMBERLY EVP, Drug Development Option exercise · Restricted Stock Units −4,564 50,756
2021-12-22 Christian Waage Director Grant or award +10,452 13,652
2021-12-22 Christian Waage Director Grant or award · Stock Option (Right to Buy) +20,903 20,903

Page 23 of 28 · 557 trades